Platinum Investment Management’s Pfizer PFE Stock Holding History

Platinum Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-50,181	Closed	-$1.7M	–	80
2017 Q3	$1.7M	Hold	50,181	–	–	0.04%	55
2017 Q2	$1.6M	Hold	50,181	–	–	0.04%	54
2017 Q1	$1.63M	Hold	50,181	–	–	0.05%	56
2016 Q4	$1.55M	Hold	50,181	–	–	0.05%	52
2016 Q3	$1.61M	Hold	50,181	–	–	0.04%	60
2016 Q2	$1.68M	Hold	50,181	–	–	0.04%	56
2016 Q1	$1.41M	Hold	50,181	–	–	0.03%	61
2015 Q4	$1.54M	Hold	50,181	–	–	0.03%	58
2015 Q3	$1.5M	Hold	50,181	–	–	0.04%	57
2015 Q2	$1.6M	Hold	50,181	–	–	0.03%	58
2015 Q1	$1.66M	Hold	50,181	–	–	0.03%	70
2014 Q4	$1.48M	Hold	50,181	–	–	0.03%	74
2014 Q3	$1.41M	Hold	50,181	–	–	0.03%	72
2014 Q2	$1.41M	Hold	50,181	–	–	0.02%	72
2014 Q1	$1.53M	Hold	50,181	–	–	0.03%	69
2013 Q4	$1.46M	Hold	50,181	–	–	0.03%	63
2013 Q3	$1.37M	Hold	50,181	–	–	0.02%	62
2013 Q2	$1.33M	Buy	+50,181	New	+$1.39M	0.03%	53

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Platinum Investment Management's PFE Position: Q4 2017 in Review

Platinum Investment Management sold out of Pfizer (PFE) in Q4 2017, closing a stake of 50,181 shares — an estimated $1.7M sold.

Platinum Investment Management first reported a position in PFE in Q2 2013 and held it in 18 quarters. The position peaked at $1.7M in Q3 2017. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Platinum Investment Management reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
Platinum Investment Management sold 50,181 Pfizer shares in Q4 2017, an estimated $1.7M.
Platinum Investment Management first reported a position in Pfizer in Q2 2013 and held it in 18 quarters.
Platinum Investment Management's Pfizer position peaked at $1.7M in Q3 2017.
2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Platinum Investment Management's 13F filing for Q4 2017, filed 15 Feb 2018.